Hypertrophy: Definition, Physiologic vs. Pathologic Types, and Molecular Basis

Hypertrophy is an increase in the size of an organ or tissue due to enlargement of constituent cells without cellular proliferation (contrast: hyperplasia = increased cell number).

Physiologic Hypertrophy (Adaptive)

  • Skeletal Muscle: Resistance training → mechanical tension → mTORC1 activation → protein synthesis → fiber hypertrophy. Satellite cell fusion adds nuclei.
  • Cardiac (Athlete's Heart): Endurance training → volume/pressure load → eccentric/concentric hypertrophy; reversible, preserved diastolic function.
  • Uterus (Pregnancy): Estrogen/progesterone + mechanical stretch → smooth muscle hypertrophy + hyperplasia.
  • Breast (Pregnancy): Ductal/lobular hyperplasia + hypertrophy.

Pathologic Hypertrophy (Maladaptive)

  • Cardiac: Pressure overload (HTN, AS, coarctation) → concentric; Volume overload (AR, MR, VSD) → eccentric. Molecular: Fetal gene reactivation (ANP, BNP, β-MHC), fibrosis, apoptosis → diastolic/systolic dysfunction → HF.
  • Adrenal (Hyperplasia/Hypertrophy): ACTH excess (Cushing's, CAH).
  • Thyroid (Goiter): TSH stimulation (iodine deficiency, Hashimoto's).
  • Prostatic (BPH): Stromal/epithelial hyperplasia + hypertrophy (androgen-driven).
  • Endometrial: Unopposed estrogen.

Molecular Signaling

  • PI3K/Akt/mTOR (growth, protein synthesis)
  • MAPK/ERK (proliferation, survival)
  • Calcineurin/NFAT (cardiac pathologic)
  • IGF-1, TGF-β, angiotensin II, catecholamines.

Key Distinction

Physiologic = reversible, functional enhancement. Pathologic = progressive, molecular reprogramming, functional decline. Both involve increased protein synthesis, but pathologic adds fibrosis, cell death, and metabolic shift.

Genetic Disorders - Related Articles